ELAVL1 and non-small cell lung carcinoma: Clinical studies have demonstrated the cytoplasmic expression of HuR was associated with lymph node metastasis in non-small cell lung carcinoma [101], colon carcinoma [147], upper urinary tract urothelial carcinoma [148], and showed a correlation with advanced diseases [111].